D.E. Shaw & Co’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Buy |
57,449
+23,652
| +70% | +$413K | ﹤0.01% | 2225 |
|
|
2025
Q1 | $425K | Sell |
33,797
-42,935
| -56% | -$540K | ﹤0.01% | 2520 |
|
|
2024
Q4 | $810K | Sell |
76,732
-3,816
| -5% | -$40.3K | ﹤0.01% | 2201 |
|
|
2024
Q3 | $1.17M | Buy |
80,548
+12,315
| +18% | +$179K | ﹤0.01% | 2103 |
|
|
2024
Q2 | $581K | Buy |
68,233
+30,056
| +79% | +$256K | ﹤0.01% | 2423 |
|
|
2024
Q1 | $390K | Buy |
+38,177
| New | +$390K | ﹤0.01% | 2500 |
|
|
2023
Q2 | – | Sell |
-24,302
| Closed | -$158K | – | 3326 |
|
|
2023
Q1 | $158K | Sell |
24,302
-19,396
| -44% | -$126K | ﹤0.01% | 2845 |
|
|
2022
Q4 | $373K | Buy |
43,698
+14,409
| +49% | +$123K | ﹤0.01% | 2823 |
|
|
2022
Q3 | $155K | Sell |
29,289
-62,834
| -68% | -$333K | ﹤0.01% | 3270 |
|
|
2022
Q2 | $391K | Sell |
92,123
-95,199
| -51% | -$404K | ﹤0.01% | 3153 |
|
|
2022
Q1 | $658K | Sell |
187,322
-62,694
| -25% | -$220K | ﹤0.01% | 3087 |
|
|
2021
Q4 | $1.67M | Sell |
250,016
-564
| -0.2% | -$3.76K | ﹤0.01% | 2480 |
|
|
2021
Q3 | $2.5M | Buy |
250,580
+40,453
| +19% | +$404K | ﹤0.01% | 1959 |
|
|
2021
Q2 | $6.49M | Buy |
210,127
+4,714
| +2% | +$146K | 0.01% | 1299 |
|
|
2021
Q1 | $8.96M | Buy |
+205,413
| New | +$8.96M | 0.01% | 1061 |
|